Fibroepithelial tumours of the breast seen in a tertiary health centre in southwestern Nigeria
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232405Keywords:
Female, Fibroadenoma, Neoplasm, Phyllodes tumourAbstract
Background: Fibroepithelial tumours of the breast are mainly fibroadenoma and phyllodes tumour. Our objective was to describe the clinical and pathological features of benign fibroepithelial tumours and then compare our findings with reports from other parts of the world.
Methods: We carried out a retrospective study of all benign fibroepithelial tumours diagnosed in the Department of Morbid Anatomy and Forensic Medicine of Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife, Nigeria from January 1, 2018 to December 31, 2022.
Results: A total of 538 cases of fibroadenoma were seen during the study period. Only 486 cases met the inclusion criteria and were then subsequently studied. Right sided tumour mass is seen in 203 (41.8%) patients, left sided masses in 173 (35.6%) patients and bilateral masses in 96 (19.8%) patients. The age of the patients ranges from 11 to 75 years. The average duration of symptoms is 16 months. The maximum length of fibroadenoma nodule ranges from 0.9cm to 15cm. The number of nodules seen in a patient range from 1 to 15. There is no association between the size of a fibroadenoma, number of the masses or the duration of symptoms before removal of the mass, and the age of the patient. Nineteen cases of phyllodes tumour were seen during the study period.
Conclusions: Our study shows that fibroadenoma is the most common fibroepithelial tumour of the breast. A sizeable proportion of patients have bilateral tumours. Phyllodes tumour is much less common.
References
Seow DYB, Tay TKY, Tan PH. Fibroepithelial lesions of the breast: A review of recurring diagnostic issues. Semin Diagn Pathol. 2022;39(5):333-43.
Quinn C, Maguire A, Rakha E. Pitfalls in breast pathology. Histopathology. 2023;82(1):140-61.
Ngbea JA, Vhritehire RA, Ojo BA, Akpor IO, Nyaga T, Ugbaje BA, et al. A Clinicopathologic review of fibroadenoma in Makurdi, North-Central Nigeria. J BioMed Res Clin Pract. 2018;1(1):81-6.
Ukweh ON, Okeke CM, Ukweh IH, Ekanem IA. Benign breast disease pattern and prevalence in Calabar- a 5 year histopathologic review. Nig J Med. 2019;28(3):320-2.
Ezike KN, Raphael S, Okwudire-Ejeh IA, Okonkwo DI. Breast lesions in a district hospital: Demographic and histopathologic characteristics. Anna Trop Pathol. 2020;11(2):113.
Feliciano YZ, Freire R, Net J, Yepes M. Ductal and lobular carcinoma in situ arising within an enlarging biopsy proven fibroadenoma. BMJ Case Rep. 2021;14(1):e237017.
Fujimoto A, Matsuura K, Kawasaki T, Ichinose Y, Nukui A, Hiratsuka M, et al. Early HER2-positive breast cancer arising from a fibroadenoma: a case report. Oxf Med Case Rep. 2021;2021(9):omab083.
Ismail S, Alaidi S, Jouni S, Kassab Y, Al-Shehabi Z. Recurrent giant fibroadenomas with transformation to cystosarcoma phyllodes in a 17-year-old girl: a rare case report from Syria. J Med Case Rep. 2019;13(1):378.
Egwuonwu OA, Anyanwu SNC, Chianakwana GU, Ihekwoaba EC. Fibroadenoma: Accuracy of clinical diagnosis in females aged 25 years or less. Niger J Clin Pract. 2016;19(3):336.
Li JJX, Tse GM. Core needle biopsy diagnosis of fibroepithelial lesions of the breast: a diagnostic challenge. Pathol. 2020;52(6):627-34.
Maritz RM, Michelow PM. Cytological criteria to distinguish phyllodes tumour of the breast from fibroadenoma. Acta Cytol. 2017;61(6):418-24.
Matei RA, Mehedinţu-Ionescu M, Paitici Ş, Georgescu EF, Donoiu A, Ghemigian AM, et al. Diagnostic difficulties in giant benign phyllodes tumor. Rom J Morphol Embryol. 2021;62(4):1035–44.
Tummidi S, Kothari K, Agnihotri M, Naik L, Sood P. Fibroadenoma versus phyllodes tumor: a vexing problem revisited! BMC Cancer. 2020;20(1):648.
Tan PH. Fibroepithelial lesions revisited: implications for diagnosis and management. Mod Pathol. 2021;34(Suppl 1):15-37.
Krings G, Bean GR, Chen YY. Fibroepithelial lesions; The WHO spectrum. Semin Diagn Pathol. 2017;34(5):438-52.
Odedina SO, Ajayi IO, Adeniji-Sofoluwe A, Morhason-Bello IO, Huo D, Olopade OI, et al. A longitudinal study of the prevalence and characteristics of breast disorders detected by clinical breast examination during pregnancy and six months postpartum in Ibadan, Southwestern Nigeria. BMC Women’s Health. 2018;18(1):152.
Egejuru RO, Nnadi IG, Duru ON. Fibroadenoma in Blacks. Health. 2017;9(11):1475-81.
Fraker JL, Clune CG, Sahni SK, Yaganti A, Vegunta S. Prevalence, impact, and diagnostic challenges of benign breast disease: a narrative review. Int J Womens Health. 2023;15:765-78.
Dessauvagie BF, Lee AHS, Meehan K, Nijhawan A, Tan PH, Thomas J, et al. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology. J Clin Pathol. 2018;71(8):672-9.
Bi J, Tang H, Lin X, Yu X, Liang Y, Zhang L, et al. Morphological features of 52 cases of breast phyllodes tumours with local recurrence. Virchows Arch. 2022;481(4):519-31.
Yoshida M, Sekine S, Ogawa R, Yoshida H, Maeshima A, Kanai Y, et al. Frequent MED12 mutations in phyllodes tumours of the breast. Br J Cancer. 2015;112(10):1703-8.
Ni Y, Tse GM. Spindle cell lesions of the breast: a diagnostic algorithm. Arch Pathol Lab Med. 2023;147(1):30-7.
Rakha EA, Brogi E, Castellano I, Quinn C. Spindle cell lesions of the breast: a diagnostic approach. Virchows Arch. 2022;480(1):127-45.
Lerwill MF, Lee AHS, Tan PH. Fibroepithelial tumours of the breast-a review. Virchows Arch. 2022;480(1):45-63.
